SmartLabs and Sonrai Analytics have announced a global strategic partnership to integrate Sonrai’s advanced AI capabilities into SmartLabs’ network of research centers. This collaboration aims to enhance precision medicine research by providing SmartLabs’ member companies with access to Sonrai’s AI-powered analytics platform, Sonrai Discovery, and exclusive AI applications tailored for accelerated scientific discovery.
SmartLabs partners with Sonrai Analytics for AI-driven research solutions.
Sonrai Discovery platform enhances precision medicine for biotech firms.
Exclusive AI applications integrate experimental and infrastructure data.
Partnership supports SmartLabs’ five managed research centers.
Accelerates biomarker discovery and therapeutic development.
Combines lab infrastructure with advanced analytics for innovation.
The partnership enables SmartLabs’ member companies to leverage Sonrai’s cloud-based AI platform, Sonrai Discovery, which streamlines diagnostic workflows and accelerates biomarker discovery by integrating imaging and omics data within a secure ecosystem. This collaboration introduces bespoke AI applications that combine experimental and infrastructure data to predict scientific outcomes, exclusively available through SmartLabs’ five managed research centers. These tools empower biotech and pharmaceutical teams to make data-driven decisions, enhancing research efficiency.
SmartLabs, a leader in flexible laboratory infrastructure, expands its model to meet the rising demand for AI-driven research solutions. By integrating Sonrai’s advanced analytics, SmartLabs equips its members with tools to manage complex datasets and uncover meaningful patterns. “We live in the age of data and AI is what unlocks its true value,” said Brian Taylor, CEO of SmartLabs. “I’m excited about this partnership as it allows us to leverage this newfound power to make a profound difference in human health moving forward.”
Sonrai’s platform supports precision medicine by enabling faster insights and deeper understanding of complex datasets. “At Sonrai, our mission is to power the most important precision medicine breakthroughs through connected data and collaborative science,” said Prof. Darragh McArt, Founder and CEO of Sonrai. “We are excited to partner with SmartLabs to bring the power of AI and advanced analytics directly to their member companies.” This collaboration accelerates the development of personalized therapeutics, positioning SmartLabs’ members at the forefront of innovation.
The partnership aligns with SmartLabs’ mission to accelerate scientific discovery and deliver life-saving therapies. By providing access to cutting-edge AI tools, SmartLabs enables its members to focus on innovation across diverse therapeutic areas and development stages. The integration of Sonrai’s analytics with SmartLabs’ infrastructure offers a comprehensive solution for biotech and pharma companies, driving transformative treatments to patients faster.
This strategic collaboration between SmartLabs and Sonrai Analytics sets a new benchmark for AI-driven research, empowering enterprises to achieve groundbreaking discoveries in precision medicine.
SmartLabs was founded in 2015 based on the belief that modern science requires a new, adaptable resourcing infrastructure as the standard to future-proof the industry and accelerate the pace of scientific breakthroughs for everyone, everywhere. The company offers the first integrated platform combining flexible lab infrastructure, operations, digital solutions, and scientific expertise. Its Managed Research Centers allow clients to access private, enterprise-grade R&D infrastructure and manufacturing solutions "as-a-service" without upfront capital investments, providing holistic end-to-end solutions for new technology and life sciences companies across all stages of the innovation lifecycle. With headquarters in Boston, SmartLabs serves diverse biotech, pharma, and new technology organizations with a unique model designed to help enable the future of the industry. For additional information, please visit: www.smartlabs.com
Sonrai Analytics, founded in 2018, is an AI precision medicine technology company. Sonrai's flagship product, Sonrai Discovery, expedites identifying and developing drug or therapeutic targets, improving patient outcomes through AI. The company partners with biotechnology and pharmaceutical companies to manage and analyze their precision medicine data.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.